The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert Says
CGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.
How to Maximize CGM Data Presented in the Ambulatory Glucose Profile: Thomas Martens, MD, Illustrates
Martens, medical director of the International Diabetes Center (IDC) in Minneapolis, highlights an IDC resource that helps target problem areas in management of hyperglycemia.
Intermittent and Continuous Glucose Monitoring: Thomas Martens, MD, Details the Differences
Martens, Director of the International Diabetes Center, in Minneapolis, highlights the differences between the 2 methods and what the research has found on each.
The Rich and Robust Data from CGM You Just Can't Get from Finger Sticks: A Talk with Thomas Martens, MD
HbA1c is Good for the Big Diabetes Picture but CGM is Key for the Data Close-Up
ACP 2025. The timely glucose data available with continuous glucose monitoring is what's needed for optimal daily diabetes control, says Tom Martens, MD.
